Qualitative or quantitative defects of nebulin

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:209182
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Qualitative or quantitative defects of nebulin (Orphanet code 209182) refers to a group of conditions caused by mutations in the NEB gene, which encodes nebulin, a giant structural protein essential for the proper assembly and function of thin filaments in skeletal muscle. Nebulin plays a critical role in regulating actin filament length, muscle contraction, and sarcomere stability. Defects in nebulin — whether the protein is reduced in quantity, absent, or structurally abnormal — are the most common cause of autosomal recessive nemaline myopathy (NM), particularly the typical congenital form. These defects primarily affect the skeletal muscular system. Patients with nebulin-related myopathies typically present with generalized muscle weakness, hypotonia (reduced muscle tone), feeding difficulties, and respiratory insufficiency, often apparent from birth or early infancy. Facial weakness, a high-arched palate, and a thin body habitus are common features. Severity is variable, ranging from severe neonatal forms with profound weakness and respiratory failure to milder childhood-onset forms with slowly progressive or relatively stable weakness. Muscle biopsy characteristically shows nemaline bodies (rod-shaped structures) within muscle fibers, though other histological patterns such as core-rod myopathy or fiber-type disproportion may also be seen. There is currently no cure or disease-specific therapy for nebulin-related myopathies. Management is supportive and multidisciplinary, focusing on respiratory support (including non-invasive ventilation), nutritional optimization, physical therapy, orthopedic management of scoliosis and joint contractures, and monitoring for cardiac complications, although cardiac involvement is uncommon. Research into gene therapy and other molecular approaches is ongoing but remains in early stages. Early intervention and coordinated care can significantly improve quality of life and functional outcomes.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Qualitative or quantitative defects of nebulin.

View clinical trials →

No actively recruiting trials found for Qualitative or quantitative defects of nebulin at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Qualitative or quantitative defects of nebulin community →

No specialists are currently listed for Qualitative or quantitative defects of nebulin.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Qualitative or quantitative defects of nebulin.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Qualitative or quantitative defects of nebulinForum →

No community posts yet. Be the first to share your experience with Qualitative or quantitative defects of nebulin.

Start the conversation →

Latest news about Qualitative or quantitative defects of nebulin

No recent news articles for Qualitative or quantitative defects of nebulin.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Qualitative or quantitative defects of nebulin

What is Qualitative or quantitative defects of nebulin?

Qualitative or quantitative defects of nebulin (Orphanet code 209182) refers to a group of conditions caused by mutations in the NEB gene, which encodes nebulin, a giant structural protein essential for the proper assembly and function of thin filaments in skeletal muscle. Nebulin plays a critical role in regulating actin filament length, muscle contraction, and sarcomere stability. Defects in nebulin — whether the protein is reduced in quantity, absent, or structurally abnormal — are the most common cause of autosomal recessive nemaline myopathy (NM), particularly the typical congenital form.

How is Qualitative or quantitative defects of nebulin inherited?

Qualitative or quantitative defects of nebulin follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Qualitative or quantitative defects of nebulin typically begin?

Typical onset of Qualitative or quantitative defects of nebulin is neonatal. Age of onset can vary across affected individuals.